Discontinued — last reported Q4 '20
An increase typically signals recent M&A activity, while a decrease may indicate impairment charges or write-downs of acquired assets.
Represents the premium paid over the fair value of net identifiable assets during acquisitions within the Neurotechnolog...
Commonly reported by medical device peers like Medtronic or Zimmer Biomet as part of segment-level intangible asset disclosures.
syk_segment_neurotechnology_and_spine_goodwill